The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
13 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $8,970,795 in first-year total cost, median $746,161.
Most frequent study sections
- Special Emphasis Panel[ZDK1 GRB-2 (J3)]2
- Special Emphasis Panel[ZDK1 GRB-2 (M3)]2
- Special Emphasis Panel[ZDK1 GRB-M (J3)]2
- Special Emphasis Panel[ZDK1 GRB-3 (O2)]1
- Special Emphasis Panel[ZDK1 GRB-J (J2)]1
Most frequent institutions
- ADVA-TEC, INC1
- BIOKIER, INC.1
- BIOTHERAPEUTICS, INC.1
- COAPTECH, LLC1
- EMOCHA MOBILE HEALTH, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | Clinical evaluation of a compliant, degradable ureteral stent to reduce patient pain and improve tolerability1R44DK125243-01 | CARTLEDGE, JENNIFER | ADVA-TEC, INC, SC | $999,827 | ZDK1 |
| 2020 | First in Human Clinical Trial of Mesenteric Visceral Lipectomy in Subjects with Type 2 Diabetes and Obesity1R44DK125159-01 | ANDREW, MARK | MEDALITY MEDICAL, LLC, NJ | $595,713 | ZDK1 |
| 2019 | Regeneration of Epidermal Nerves in Human Diabetic Neuropathy2R44DK104512-05 | HANSEN, ANGELA | WINSANTOR, INC., CA | $1,000,000 | ZRG1 |
| 2019 | First-In-Human Feasibility Trial of Break Wave - The Office-Based Lithotripsy Solution2R44DK109779-04A1 | LEVY, OREN | SONOMOTION, INC., CA | $999,958 | ZDK1 |
| 2019 | Development of an oral therapeutic to mimic the anti-diabetic effects of gastric bypass surgery2R44DK107080-04 | SZEWCZYK, JERZY | BIOKIER, INC., NC | $999,864 | ZDK1 |
| 2019 | Assessment of Multiple Dose Administration of Glucagon Receptor Blocker REMD477 in Type 1 Diabetes2R44DK108305-04 | KLEIN, SAMUELTHAI, DUNG "ZUNG" | REMD BIOTHERAPEUTICS, INC., CA | $993,326 | ZDK1 |
| 2019 | Proof of Extended Absorption of Liothyronine from PolyZincLiothyronine (PZL) inHumans2R44DK116396-02A1 | PICCARIELLO, THOMAS | SYNTHONICS, INC., VA | $970,548 | ZDK1 |
| 2019 | Percutaneous Ultrasound Gastrostomy: Clinical Evaluation of a Novel Method for Feeding Tube Placement2R44DK115325-02A1 | CAROLAN, HOWARD | COAPTECH, LLC, MD | $643,804 | ZDK1 |
| 2019 | A Clinical Study of Latiglutenase as a Treatment for Type 1 Diabetics with Celiac Disease1R44DK121606-01 | MAAHS, DAVID MATTHEWSYAGE, JACK A. | IMMUNOGENICS, LLC, CA | $293,257 | ZDK1 |
| 2019 | Effects of Abscisic Acid on Insulin Sensitivity1R44DK120338-01A1 | HONTECILLAS, RAQUEL | BIOTHERAPEUTICS, INC., VA | $281,612 | ZDK1 |
| 2019 | Clinical feasibility study of autonomous tibial nerve stimulator for overactive bladder1R44DK121578-01A1 | JACOBSON, PETER | NINE CONTINENTS MEDICAL, INC., CA | $224,700 | ZDK1 |
| 2019 | Development and Evaluation of a Mobile Directly Observed Therapy Smartphone App for Immunosuppressive Adherence in Transplant Patients1R44DK123978-01 | SEGEV, DORRY L.SEIGUER, SEBASTIAN | EMOCHA MOBILE HEALTH, INC., MD | $222,025 | ZDK1 |
| 2018 | Validation of Advanced Urinary Prosthesis for Improved Urologic Management and Outcomes of Urinary Retention Disorders2R44DK109865-02A1 | COLONE, WILLIAM | SPINAL SINGULARITY, INC., CA | $746,161 | ZDK1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.